TetraScience’s $80 Million Series B Financing

Latham & Watkins LLP represented TetraScience in the transaction.

TetraScience closed its US$80 million Series B to capitalize on the unprecedented demand for its category-defining industry data cloud.

Co-led by new investors Insight Partners and Alkeon Capital, the company will use the funds to aggressively ramp its go-to-market capabilities, expand its industry leading technical capabilities, and grow its team of scientific experts. The round comes on the heels of the company’s 10x revenue growth in 2020. 

TetraScience is a cloud technology innovator powering transformational changes in life sciences R&D. It’s the industry’s only cloud-native data platform, combined with the largest and fastest-growing network of life science integrations and deep domain expertise, to deliver a future-proof solution for harnessing the power of R&D data.

Latham & Watkins LLP represented TetraScience in the financing with a Boston-based emerging companies team led by partners John Chory (Picture) and Spencer Ricks, with associates Peter Prial and Martha Anderson.

Involved fees earner: Martha Louise Anderson – Latham & Watkins; John Chory – Latham & Watkins; Peter Prial – Latham & Watkins; Spencer Ricks – Latham & Watkins;

Law Firms: Latham & Watkins;

Clients: TetraScience;

Author: Martina Bellini